JCCC Research Seminar featuring Dr. Sara Hurvitz
Talk title TBA
- Date: February 18, 2021 12:00 PM - 1:00 PM
- Location: Virtual event (see description below)
Los Angeles, California 90095
NOTE: This is event is being held virtually. Registration is required. Please visit this Zoom link to register and attend: cancer.ucla.edu/JCCCSeminarSeries.
Sara Hurvitz, M.D.
Associate Professor, Department of Medicine, Hematology/Oncology
Director, Hematology/Oncology Breast Cancer Program
Co-Director, Santa Monica-UCLA Outpatient, Hematology/Oncology Practice
Medical Director, JCCC Clinical Research Unit
Dr. Sara Hurvitz is interested in designing and implementing phase I and II (translational) breast cancer clinical trials. She is particularly interested in the development and testing of new targeted therapies for the treatment of breast cancer. Hurvitz is also interested in studying the gene expression patterns in a variety of breast cancer populations, and evaluating these patterns to detect new subtypes of breast cancer that may be more accurately targeted by novel therapies.
Light lunch served
Sponsored by the UCLA Jonsson Comprehensive Cancer Center Signal Transduction and Therapeutics research program